Finance

Lists
Why is 4564 up 6.25%?
Dive Deeper
4564:TYO
OncoTherapy Science, Inc.
¥17.00
+6.25%
(+1.00) 1D
Nov 10, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4564...
Open
¥17
High
¥18
Low
¥16
Mkt. cap
6.94B
Avg. vol.
199.45M
Volume
241.22M
52-wk high
¥34
52-wk low
¥16
EPS
-¥2
Shares outstanding
147.03M
No. of employees
46
Open
¥17
High
¥18
Low
¥16
Mkt. cap
6.94B
Avg. vol.
199.45M
Volume
241.22M
52-wk high
¥34
52-wk low
¥16
EPS
-¥2
Shares outstanding
147.03M
No. of employees
46
News stories
From web sources and news partners
About OncoTherapy Science, Inc.
CEO-
Employees46
FoundedApr 6, 2001
Headquarters-
SectorHealth Care
IndustryBiotechnology
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
166.00M
211.00M
170.00M
165.00M
Cost of goods sold
278.00M
362.00M
335.00M
345.00M
Cost of revenue
278.00M
362.00M
335.00M
345.00M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
107.00M
-36.00M
120.00M
103.00M
Operating expense
107.00M
-36.00M
120.00M
103.00M
Total operating expenses
385.00M
326.00M
455.00M
448.00M
Operating income
-219.00M
-115.00M
-285.00M
-283.00M
Other non operating income
-6.00M
-8.00M
-1.00M
-3.00M
EBT including unusual items
-228.00M
-126.00M
-288.00M
-285.00M
EBT excluding unusual items
-226.00M
-125.00M
-287.00M
-285.00M
Income tax expense
-
1.00M
-
1.00M
Effective tax rate
-
-0.79%
-
-0.35%
Other operating expenses
-
-
-
-
Net income
-228.00M
-127.00M
-288.00M
-286.00M
Net profit margin
-137.35%
-60.19%
-169.41%
-173.33%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-1.00M
-
-
Net interest expenses
-
-1.00M
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps